Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy

Combining stem cells with biomaterial scaffolds provides a promising strategy for the development of drug delivery systems. Here we propose an innovative immunotherapeutic organoid by housing human mesenchymal stromal cells (MSCs), gene-modified for the secretion of an anti-CD33-anti-CD3 bispecific...

Descripción completa

Detalles Bibliográficos
Autores principales: Aliperta, Roberta, Welzel, Petra B., Bergmann, Ralf, Freudenberg, Uwe, Berndt, Nicole, Feldmann, Anja, Arndt, Claudia, Koristka, Stefanie, Stanzione, Marcello, Cartellieri, Marc, Ehninger, Armin, Ehninger, Gerhard, Werner, Carsten, Pietzsch, Jens, Steinbach, Jörg, Bornhäuser, Martin, Bachmann, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311951/
https://www.ncbi.nlm.nih.gov/pubmed/28205621
http://dx.doi.org/10.1038/srep42855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311951/
https://www.ncbi.nlm.nih.gov/pubmed/28205621
http://dx.doi.org/10.1038/srep42855

Ejemplares similares